Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
20.76
+0.40 (1.96%)
At close: Nov 4, 2024, 4:00 PM
22.65
+1.89 (9.10%)
After-hours: Nov 4, 2024, 7:59 PM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 20.67, with a low estimate of 11 and a high estimate of 25. The average target predicts a decrease of -0.43% from the current stock price of 20.76.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HIMS stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $23 → $25 | Strong Buy | Maintains | $23 → $25 | +20.42% | Oct 21, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $20 → $23 | Strong Buy | Maintains | $20 → $23 | +10.79% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | -3.66% | Sep 13, 2024 |
| Needham | Needham | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +15.61% | Aug 22, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $16 → $23 | Hold | Maintains | $16 → $23 | +10.79% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
1.42B
from 872.00M
Increased by 63.07%
Revenue Next Year
1.91B
from 1.42B
Increased by 34.39%
EPS This Year
0.24
from -0.11
EPS Next Year
0.36
from 0.24
Increased by 54.27%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.5B | 2.2B | 2.8B | ||
| Avg | 1.4B | 1.9B | 2.3B | ||
| Low | 1.3B | 1.6B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 73.4% | 53.4% | 47.4% | ||
| Avg | 63.1% | 34.4% | 17.9% | ||
| Low | 53.7% | 15.8% | -0.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.46 | 0.62 | 1.01 | ||
| Avg | 0.24 | 0.36 | 0.55 | ||
| Low | 0.14 | 0.08 | 0.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 162.9% | 176.7% | ||
| Avg | - | 54.3% | 51.5% | ||
| Low | - | -66.7% | -51.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.